SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Micrologix biotech
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Larry G. who wrote (453)3/13/1999 11:45:00 AM
From: Sean Janzen  Read Replies (2) of 792
 
The low volume / low share price is a supply and demand issue. I don't find this event worrisome.

It is my understanding that 80% of drugs that enter Phase I successfully reach Phase II. I don't expect to see a huge appreciation in the share price associated with completion of Phase I.

MBI must continue to do what they are doing. They must continue to develop their drug portfolio and bring more drugs into human clinical testing.

Any big gains in MBI are probably 2-3 years away. It is my intention to accumulate MBI on dips below $2.00.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News